Clinical trial
Proteome-based Personalized Immunotherapy of Malignant Brain Tumors
NCT01759810 is registered in ClinicalTrials.gov with NeuroVita Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Proteome-based Personalized Immunotherapy of Malignant Brain Tumors
- Lead sponsor
- NeuroVita Clinic
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- December 31, 2012
- Completion date
- December 31, 2020
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.